🔗 Share this article

An underground economy for unapproved slimming drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Investigational Drug Gaining Traction Online

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are urged to message these accounts privately for supplier links, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and claims of next-day UK delivery. Vendors market the drug there before directing customers to WhatsApp for purchases.

Understanding The Experimental Drug

Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Medical Professionals Express Concerns

Nevertheless, physicians and chemists have warned that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could result in users administering substances of uncertain source.

Some experts said the demand for the experimental drug could be linked to the rising cost of approved slimming products such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate medicines, marketing, and customer laws, potentially leading to penalties, prosecution or imprisonment.

Platform Reaction and Content Elimination

Based on the social media company, the service has removed violative content and banned associated keywords and search suggestions. The organization said it was dedicated to maintaining the platform secure and investing in strengthening enforcement strategies.

Online Marketplace Activities

Research also found groups with up to 9,000 participants marketing retatrutide using Telegram's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately displays groups with thousands of members, filled with photos of weight loss, positive testimonials and step-by-step instructions for mixing or administering at home.

Within moments of entering one community, a vendor posted contact information, where most transactions occur. The seller sent an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about body mass, medical conditions or past usage.

Item Details and Costs

Inside these groups, messages display dark colored packages with postal service stickers, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with purified liquid, or pre-filled injectors usually sold at 160 pounds for 20mg. When questioned how much time a pen should last, sellers give conflicting answers ranging from a several days to “depends on your body”.

Platform Moderation and Security Actions

A representative for the messaging service said it regularly moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering materials they cannot confirm. Even if the research behind retatrutide is valid, these digital versions may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent price rises for authorized slimming medications such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake injections are highly risky. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she said.

Her staff has previously encountered patients injured by self-injection from unconfirmed sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”

Producer Statement

A representative from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Therefore at this point no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a Lilly investigational product not yet authorized … may subject users to potentially significant medical dangers”.